University of Bergen
Bergen, Norway
NCT Number: NCT06364163
High cholesterol concentration is a major risk factor for cardiovascular disease (CVD), and consumption of fish has been associated with a lower CVD risk in several studies. The beneficial health effects of consuming fish have traditionally been ascribed to the long-chain PUFA (LC-PUFA) EPA (C20:5n-3) and DHA (C22:6n-3), although consumption of fish oils or concentrates with high EPA and DHA contents does not affect the cholesterol concentration in humans and lowers the cholesterol concentration in rats and mice only when given in very high doses. Fish oils contain a plethora of fatty acids besides EPA and DHA, and in recent years, increased focus has been on the long-chain MUFA (LC-MUFA) cetoleic acid (C22:1n-11). Cetoleic acid is found in high amounts in oils from certain fish species such as herring, which has relatively low contents of both EPA and DHA. The investigators have recently summarised and meta-analysed the available literature that investigates the effects of diets containing fish oils or fish oil concentrates that have a high content of cetoleic acid but low or no content of EPA and DHA on cholesterol concentration in rodents, showing that cetoleic acid-rich fish oils and concentrates prevent high cholesterol concentration.
This study is active but is not currently recruiting participants.
20 year–65 year
All sexes
Interventional
Not applicable
Bergen, Norway
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Capsules containing herring oil concentrate, taken daily for 8 weeks.
Capsules containing control oil, taken daily for 8 weeks.
Time frame: 8 weeks
LDL-cholesterol will be measured in fasting serum samples
Time frame: 8 weeks
HDL-cholesterol will be measured in fasting serum samples
Time frame: 8 weeks
Total cholesterol will be measured in fasting serum samples
Time frame: 8 weeks
Lipoproteins will be measured in fasting serum samples
Time frame: 8 weeks
Metabolites of amino acids will be measured in fasting serum samples
Time frame: 8 weeks
Metabolites in the one-carbon pathway will be measured in fasting serum samples
Time frame: 8 weeks
Leukocytes will be isolated from fasting serum before quantification of fatty acids
Time frame: 8 weeks
Glucose will be measured in serum sampled in fasting condition
Time frame: 8 weeks
Insulin will be measured in serum sampled in fasting condition
Time frame: 8 weeks
Percent body fat will be measured using bioimpedance
University of Bergen
Other
A Study on the Effect of Consuming a Herring Oil Concentrate on LDL Cholesterol Concentration in Adults With Overweight or Obesity
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07347678
Dyslipidemias, High Cholesterol
Brisbane, Queensland, Australia
View Trial DetailsNCT07378514
Blood Clots, Cardiovascular Diseases
View Trial DetailsNCT07220213
Blood Sugar; High, Body Weight
Birmingham, Alabama, United States
View Trial DetailsNCT07126587
Body Weight, Cancer
Chapel Hill, North Carolina, United States
View Trial Details